Secondary Neoplasm — Trials

Secondary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 6,412 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05319015	Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus	recruiting	Phase 2	30	University of Texas Southwestern Medical CenterOTHER	1	Sep 16, 2026	clinicaltrials
NCT05807932	Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML	recruiting	Phase 1 / Phase 2	38	Heinrich-Heine University, DuesseldorfOTHER	1	Sep 16, 2026